VAXXINITY INC A by Vaxxinity, Inc. Financials - Benzinga

VAXXINITY INC A by Vaxxinity, Inc.

VAXXOTCEM

Trade with Public

Trade with Public

$0.1111

At close: May 17, 5:00 PM EST

$0.00010

-0.11-99.91%

After Hours: Nov 10, 8:41 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

VAXXINITY INC A by Vaxxinity, Inc. Financials

VAXXINITY INC A by Vaxxinity, Inc. (VAXX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Dow Jumps Over 400 Points; US Adds 175,000 Jobs In April

Avi Kapoor

Vaxxinity Q4 EPS $(0.09) Beats $(0.10) Estimate

Vaxxinity (NASDAQ:VAXX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the same

Happy Mohamed

Recap: Vaxxinity Q3 Earnings

Benzinga Insights

PRO
Vaxxinity Q3 EPS $(0.10) Beats $(0.12) Estimate

Vaxxinity (NASDAQ:VAXX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the

Benzinga Newsdesk

PRO
Vaxxinity Q2 EPS $(0.11) Up From $(0.14) YoY

Vaxxinity (NASDAQ:VAXX) reported quarterly losses of $(0.11) per share. This is a 21.43 percent increase over losses of $(0.14) per share from the same period last year.

Benzinga Newsdesk

Recap: Vaxxinity Q1 Earnings

Vaxxinity (NASDAQ:VAXX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Vaxxinity beat estimated earnings by 6.25%, reporting an EPS of $-0.15 versus an estimate of $-0.16.

Benzinga Insights